Supporting previous descriptions from clinical series, we found a predominance of breast-ACC among women characterized by ER-negative/PR-negative hormone receptor status, rare regional LN involvement, and excellent survival. The gene discussed is NR4A1; the disease is adrenal cortex carcinoma.